K162607 is an FDA 510(k) clearance for the BeneVision Central Monitoring System. This device is classified as a System, Network And Communication, Physiological Monitors (Class II - Special Controls, product code MSX).
Submitted by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on April 20, 2017, 213 days after receiving the submission on September 19, 2016.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2300.